The global Next Generation Diabetes Therapy and Drug Delivery market was valued at US$ 1757.8 million in 2023 and is anticipated to reach US$ 7852.9 million by 2030, witnessing a CAGR of 23.3% during the forecast period 2024-2030.

Next Generation Diabetes Therapy and Drug Delivery Market

Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Next Generation Diabetes Therapy and Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Diabetes Therapy and Drug Delivery.

Report Scope

The Next Generation Diabetes Therapy and Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Diabetes Therapy and Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Next Generation Diabetes Therapy and Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Next Generation Diabetes Therapy and Drug Delivery Market Report

Report Metric	Details
Report Name	Next Generation Diabetes Therapy and Drug Delivery Market
Accounted market size in 2023	US$ 1757.8 million
Forecasted market size in 2030	US$ 7852.9 million
CAGR	23.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Inhalable Insulin Oral Insulin Insulin Patches CGM Systems Artificial Pancreas
Segment by Application	Diagnostic/Clinics ICUs Home Healthcare
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Abbott Laboratories, Medtronic, Sanofi, Novo Nordisk, MannKind Corporation, Enteris BioPharma, Dexcom, Senseonics, Medtech, Synertech, Zosano Pharma, Relmada Therapeutics, Eli Lilly and Company, Transdermal Specialties
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Diabetes Therapy and Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Next Generation Diabetes Therapy and Drug Delivery Market growing?

Ans: The Next Generation Diabetes Therapy and Drug Delivery Market witnessing a CAGR of 23.3% during the forecast period 2024-2030.

What is the Next Generation Diabetes Therapy and Drug Delivery Market size in 2030?

Ans: The Next Generation Diabetes Therapy and Drug Delivery Market size in 2030 will be US$ 7852.9 million.

Who are the main players in the Next Generation Diabetes Therapy and Drug Delivery Market report?

Ans: The main players in the Next Generation Diabetes Therapy and Drug Delivery Market are Johnson & Johnson, Abbott Laboratories, Medtronic, Sanofi, Novo Nordisk, MannKind Corporation, Enteris BioPharma, Dexcom, Senseonics, Medtech, Synertech, Zosano Pharma, Relmada Therapeutics, Eli Lilly and Company, Transdermal Specialties

What are the Application segmentation covered in the Next Generation Diabetes Therapy and Drug Delivery Market report?

Ans: The Applications covered in the Next Generation Diabetes Therapy and Drug Delivery Market report are Diagnostic/Clinics, ICUs, Home Healthcare

What are the Type segmentation covered in the Next Generation Diabetes Therapy and Drug Delivery Market report?

Ans: The Types covered in the Next Generation Diabetes Therapy and Drug Delivery Market report are Inhalable Insulin, Oral Insulin, Insulin Patches, CGM Systems, Artificial Pancreas

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Inhalable Insulin

1.2.3 Oral Insulin

1.2.4 Insulin Patches

1.2.5 CGM Systems

1.2.6 Artificial Pancreas

1.3 Market by Application

1.3.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Diagnostic/Clinics

1.3.3 ICUs

1.3.4 Home Healthcare

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Perspective (2019-2030)

2.2 Next Generation Diabetes Therapy and Drug Delivery Growth Trends by Region

2.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Region (2019-2024)

2.2.3 Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2025-2030)

2.3 Next Generation Diabetes Therapy and Drug Delivery Market Dynamics

2.3.1 Next Generation Diabetes Therapy and Drug Delivery Industry Trends

2.3.2 Next Generation Diabetes Therapy and Drug Delivery Market Drivers

2.3.3 Next Generation Diabetes Therapy and Drug Delivery Market Challenges

2.3.4 Next Generation Diabetes Therapy and Drug Delivery Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue

3.1.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue (2019-2024)

3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2019-2024)

3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Next Generation Diabetes Therapy and Drug Delivery Revenue

3.4 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio

3.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2023

3.5 Next Generation Diabetes Therapy and Drug Delivery Key Players Head office and Area Served

3.6 Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service

3.7 Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Type

4.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Type (2019-2024)

4.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2025-2030)

5 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Application

5.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Application (2019-2024)

5.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)

6.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)

6.4 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)

7.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)

7.4 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)

8.2 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2019-2024)

8.4 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)

9.2 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)

9.4 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)

10.2 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)

10.4 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Detail

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Introduction

11.1.4 Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.1.5 Johnson & Johnson Recent Development

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Detail

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Introduction

11.2.4 Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.2.5 Abbott Laboratories Recent Development

11.3 Medtronic

11.3.1 Medtronic Company Detail

11.3.2 Medtronic Business Overview

11.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Introduction

11.3.4 Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.3.5 Medtronic Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Detail

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Introduction

11.4.4 Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.4.5 Sanofi Recent Development

11.5 Novo Nordisk

11.5.1 Novo Nordisk Company Detail

11.5.2 Novo Nordisk Business Overview

11.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Introduction

11.5.4 Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.5.5 Novo Nordisk Recent Development

11.6 MannKind Corporation

11.6.1 MannKind Corporation Company Detail

11.6.2 MannKind Corporation Business Overview

11.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Introduction

11.6.4 MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.6.5 MannKind Corporation Recent Development

11.7 Enteris BioPharma

11.7.1 Enteris BioPharma Company Detail

11.7.2 Enteris BioPharma Business Overview

11.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Introduction

11.7.4 Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.7.5 Enteris BioPharma Recent Development

11.8 Dexcom

11.8.1 Dexcom Company Detail

11.8.2 Dexcom Business Overview

11.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Introduction

11.8.4 Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.8.5 Dexcom Recent Development

11.9 Senseonics

11.9.1 Senseonics Company Detail

11.9.2 Senseonics Business Overview

11.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Introduction

11.9.4 Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.9.5 Senseonics Recent Development

11.10 Medtech

11.10.1 Medtech Company Detail

11.10.2 Medtech Business Overview

11.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Introduction

11.10.4 Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.10.5 Medtech Recent Development

11.11 Synertech

11.11.1 Synertech Company Detail

11.11.2 Synertech Business Overview

11.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Introduction

11.11.4 Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.11.5 Synertech Recent Development

11.12 Zosano Pharma

11.12.1 Zosano Pharma Company Detail

11.12.2 Zosano Pharma Business Overview

11.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Introduction

11.12.4 Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.12.5 Zosano Pharma Recent Development

11.13 Relmada Therapeutics

11.13.1 Relmada Therapeutics Company Detail

11.13.2 Relmada Therapeutics Business Overview

11.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Introduction

11.13.4 Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.13.5 Relmada Therapeutics Recent Development

11.14 Eli Lilly and Company

11.14.1 Eli Lilly and Company Company Detail

11.14.2 Eli Lilly and Company Business Overview

11.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Introduction

11.14.4 Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.14.5 Eli Lilly and Company Recent Development

11.15 Transdermal Specialties

11.15.1 Transdermal Specialties Company Detail

11.15.2 Transdermal Specialties Business Overview

11.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Introduction

11.15.4 Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

11.15.5 Transdermal Specialties Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Eli Lilly and Company

Transdermal Specialties

List of Tables

Table 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Inhalable Insulin

Table 3. Key Players of Oral Insulin

Table 4. Key Players of Insulin Patches

Table 5. Key Players of CGM Systems

Table 6. Key Players of Artificial Pancreas

Table 7. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2019-2024)

Table 11. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2025-2030)

Table 13. Next Generation Diabetes Therapy and Drug Delivery Market Trends

Table 14. Next Generation Diabetes Therapy and Drug Delivery Market Drivers

Table 15. Next Generation Diabetes Therapy and Drug Delivery Market Challenges

Table 16. Next Generation Diabetes Therapy and Drug Delivery Market Restraints

Table 17. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players (2019-2024)

Table 19. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2023)

Table 20. Ranking of Global Top Next Generation Diabetes Therapy and Drug Delivery Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service

Table 24. Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2019-2024)

Table 28. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2025-2030)

Table 30. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2019-2024)

Table 32. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2025-2030)

Table 34. North America Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030) & (US$ Million)

Table 49. Johnson & Johnson Company Detail

Table 50. Johnson & Johnson Business Overview

Table 51. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product

Table 52. Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 53. Johnson & Johnson Recent Development

Table 54. Abbott Laboratories Company Detail

Table 55. Abbott Laboratories Business Overview

Table 56. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product

Table 57. Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 58. Abbott Laboratories Recent Development

Table 59. Medtronic Company Detail

Table 60. Medtronic Business Overview

Table 61. Medtronic Next Generation Diabetes Therapy and Drug Delivery Product

Table 62. Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 63. Medtronic Recent Development

Table 64. Sanofi Company Detail

Table 65. Sanofi Business Overview

Table 66. Sanofi Next Generation Diabetes Therapy and Drug Delivery Product

Table 67. Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 68. Sanofi Recent Development

Table 69. Novo Nordisk Company Detail

Table 70. Novo Nordisk Business Overview

Table 71. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product

Table 72. Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 73. Novo Nordisk Recent Development

Table 74. MannKind Corporation Company Detail

Table 75. MannKind Corporation Business Overview

Table 76. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product

Table 77. MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 78. MannKind Corporation Recent Development

Table 79. Enteris BioPharma Company Detail

Table 80. Enteris BioPharma Business Overview

Table 81. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product

Table 82. Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 83. Enteris BioPharma Recent Development

Table 84. Dexcom Company Detail

Table 85. Dexcom Business Overview

Table 86. Dexcom Next Generation Diabetes Therapy and Drug Delivery Product

Table 87. Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 88. Dexcom Recent Development

Table 89. Senseonics Company Detail

Table 90. Senseonics Business Overview

Table 91. Senseonics Next Generation Diabetes Therapy and Drug Delivery Product

Table 92. Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 93. Senseonics Recent Development

Table 94. Medtech Company Detail

Table 95. Medtech Business Overview

Table 96. Medtech Next Generation Diabetes Therapy and Drug Delivery Product

Table 97. Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 98. Medtech Recent Development

Table 99. Synertech Company Detail

Table 100. Synertech Business Overview

Table 101. Synertech Next Generation Diabetes Therapy and Drug Delivery Product

Table 102. Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 103. Synertech Recent Development

Table 104. Zosano Pharma Company Detail

Table 105. Zosano Pharma Business Overview

Table 106. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product

Table 107. Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 108. Zosano Pharma Recent Development

Table 109. Relmada Therapeutics Company Detail

Table 110. Relmada Therapeutics Business Overview

Table 111. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product

Table 112. Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 113. Relmada Therapeutics Recent Development

Table 114. Eli Lilly and Company Company Detail

Table 115. Eli Lilly and Company Business Overview

Table 116. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product

Table 117. Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 118. Eli Lilly and Company Recent Development

Table 119. Transdermal Specialties Company Detail

Table 120. Transdermal Specialties Business Overview

Table 121. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product

Table 122. Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024) & (US$ Million)

Table 123. Transdermal Specialties Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Type: 2023 VS 2030

Figure 3. Inhalable Insulin Features

Figure 4. Oral Insulin Features

Figure 5. Insulin Patches Features

Figure 6. CGM Systems Features

Figure 7. Artificial Pancreas Features

Figure 8. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application: 2023 VS 2030

Figure 10. Diagnostic/Clinics Case Studies

Figure 11. ICUs Case Studies

Figure 12. Home Healthcare Case Studies

Figure 13. Next Generation Diabetes Therapy and Drug Delivery Report Years Considered

Figure 14. Global Next Generation Diabetes Therapy and Drug Delivery Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Next Generation Diabetes Therapy and Drug Delivery Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region: 2023 VS 2030

Figure 17. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players in 2023

Figure 18. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2023

Figure 20. North America Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2019-2030)

Figure 22. United States Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2019-2030)

Figure 26. Germany Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2019-2030)

Figure 34. China Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2019-2030)

Figure 42. Mexico Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Share by Country (2019-2030)

Figure 46. Turkey Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Johnson & Johnson Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 49. Abbott Laboratories Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 50. Medtronic Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 51. Sanofi Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 52. Novo Nordisk Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 53. MannKind Corporation Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 54. Enteris BioPharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 55. Dexcom Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 56. Senseonics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 57. Medtech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 58. Synertech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 59. Zosano Pharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 60. Relmada Therapeutics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 61. Eli Lilly and Company Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 62. Transdermal Specialties Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions